Wednesday, February 10, 2010, 9:11am EST - Canadian Markets open in 19 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

Cubist Pharmaceuticals Inc. (CBST)

On Feb 9: 20.58 USD   0.00 (0.00%)  
MORE ON CBST
Quotes
Charts
News & Info
HereHeadlines
Company
Analyst Coverage
Ownership
Financials
Headlines Get Headlines for:
Tue, Feb 2, 2010
Four Stock Ideas for a Muddled Market
at Seeking Alpha (Tue, Feb 2)
Fri, Jan 29, 2010
5-Star Stocks on the Upswing
at Motley Fool (Fri, Jan 29)
Wed, Jan 27, 2010
Today's 5-Star Movers
at Motley Fool (Wed, Jan 27)
Sat, Jan 23, 2010
New Star Analyst Rankings for Cubist Pharmaceuticals, Inc.
StarMine (Sat, Jan 23)
Fri, Jan 22, 2010
Cubist Misses Estimate
Zacks.com (Fri, Jan 22)
Thu, Jan 21, 2010
Cubist Pharmaceuticals, Inc. Q4 2009 Earnings Call Transcript
at Seeking Alpha (Thu, Jan 21)
Cubist 4Q profit tumbles without tax benefit
AP (Thu, Jan 21)
Cubist Pharmaceuticals Fourth Quarter 2009 Earnings Call scheduled for 5:00 pm ET today
Vcall (Thu, Jan 21)
CUBIST PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
EDGAR Online (Thu, Jan 21)
Cubist Pharmaceuticals Announces Full Year 2009 Total Net Revenues of $562.1 Million
Business Wire (Thu, Jan 21)
Q4 2009 Cubist Pharmaceuticals, Inc. Earnings Release - Time Not Supplied
CCBN (Thu, Jan 21)
Thu, Jan 14, 2010
A Closer Look at Cubist Pharma
at Seeking Alpha (Thu, Jan 14)
Wed, Jan 13, 2010
Correction: Cubist Revenue Outlook
AP (Wed, Jan 13)
Cubist drug Cubicin posted $524M in '09 sales
at bizjournals.com (Wed, Jan 13)
CUBIST PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an
EDGAR Online (Wed, Jan 13)
Mon, Jan 11, 2010
Cubist reports $560.3 million in 2009 revenue
AP (Mon, Jan 11)
Cubist Pharmaceuticals Announces Full Year 2009 Total Net Revenues of $562.1 Million
Business Wire (Mon, Jan 11)
Fri, Jan 8, 2010
PhRMA adds 7 biotech companies to its membership
AP (Fri, Jan 8)
Thu, Dec 31, 2009
Robert Auer Of SBAuer Funds LLC Talks About His Investment Strategy And The Outlook For The Sector
Wall Street Transcript (Thu, Dec 31)
The FDA (Still) Hates Antibiotic Makers
at Motley Fool (Thu, Dec 31)
Older Headlines
View headlines from:

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Headlines for Another Symbol:
Symbol Lookup
Latest News Canadian Indices